Navigation Links
Cellular Biomedicine Group Announces Positive Interim Results from Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)
Date:9/6/2013

, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards. To learn more about CBMG, please visit: www.cellbiomedgroup.com

Forward-Looking Statements
Statements in this press release relating to plans, strategies, trends, specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "expects," "plans," "intends," "estimates," "potential," or "continue," or similar terms or the negative of these terms. Although CBMG believes the expectations reflected in the forward-looking statements are reasonable, they cannot guarantee that future results, levels of activity, performance or achievements will be obtained. CBMG does not have any obligation to update these forward-looking statements other than as required by law.

Contact:

Jeff Ramson 
Investor Relations
ProActive Capital Group
+1 646 863 6341
Jramson@proactivecapital.com

Sarah Kelly 
Director of Corporate Communications, CBMG
+1 650 566 5064
'/>"/>

SOURCE Cellular Biomedicine Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cellular Dynamics Launches MyCell™ Services
2. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
3. CeeTox and Cellular Dynamics Collaborate to Offer Predictive In Vitro Test for Cardiotoxicity Using Human iPSC-derived Cells
4. EastBridge Investment Group Announces Merger with Cellular Biomedicine Group
5. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
6. Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
7. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
8. Cellular Dynamics Announces Presentations at the Society of Toxicologys 52nd Annual Meeting Demonstrating the Expanding Impact of iPSC-Derived Human Cells on Toxicology Assay Development
9. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
10. Cellular Dynamics International Opens Facility in California, Leasing Space from the Buck Institute to Derive and Bank Human Induced Pluripotent Stem Cells
11. Exosome Diagnostics Presents Data Demonstrating Clinical Applications of Exosome Technology in Brain Cancer, Prostate Cancer, and Alzheimers Disease at the International Society for Extracellular Vesicles 2013 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 06, 2015 Research and Markets ... addition of the "Global Insulin Patch Market ... Highly advanced technology like ultrasound and iontophoresis ... insulin patches. Depending upon the type of technique, ... of reach of several patients. In long-term, it ...
(Date:5/6/2015)...   CEFALY Technology , the creators of the ... for use prior to the onset of migraine pain, ... at the EUROHEADPAIN - Midterm Meeting at the International ... , from May 14-17, 2015. On May ... major European research project focused on migraines, CEFALY ...
(Date:5/6/2015)... SAN ANTONIO , May 6, 2015   GenSpera, ... "Injectable Cancer Compositions" has entered the national phase application process ... , Eurasia, Japan , China ... the United States . When awarded, the resulting patent ... property around its entire platform technology, including its lead drug ...
Breaking Medicine Technology:Global Insulin Patch Market Opportunity Analysis 2015 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
... Therapy Reduces TNF-alpha Production Through Inhibition,of PDE-4 ... /PRNewswire/ -- Anacor,Pharmaceuticals, a privately held pharmaceutical ... Phase 1 trial of,AN2728, a first-in-class topical ... The trial showed AN2728 to be,well-tolerated, with ...
... and Pharmacokinetics Similar to IV Doses in,Phase ... 06, 2007 /PRNewswire-FirstCall/ --,Genta Incorporated announced the ... Company's lead anti-cancer drug,Genasense(R) (oblimersen sodium) injection, ... injection, as well,as by brief intravenous (IV) ...
Cached Medicine Technology:Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory,Compound, Shows Efficacy in Psoriasis 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 3Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 4
(Date:5/6/2015)... Illinois (PRWEB) May 06, 2015 RPS Revolution ... take on the tried and true Rock Paper Scissors game ... With fun characters that encourage storytelling and easy to learn ... new twist on an old favorite. RPS Revolution ... it into whimsical characters that are grouped in set of ...
(Date:5/6/2015)... Imprivata ® (NYSE: IMPR), the ... Ting will lead a discussion about the Internet of ... user authentication challenges, during Citrix Synergy (May ... on the benefits of creating a network of IP-connected ... patients can share information. It will also emphasize the ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, after ... Florida while under the influence of Flakka, according to ... by CBS4’s Peter D’Oench records Doby distraught in a parking ... one year old. The drug treatment center in Florida who ... The residents polled by CBS Miami express concern about the ...
(Date:5/6/2015)... The Canton Group is joining Lardarius Webb ... annual charity softball game. The event takes place on Friday, ... Past years guests include Joe Flacco, John Harbaugh, Ed Reed ... sale if you are interested in attending. , The ... as SOAR Baltimore and The CollegeBound Foundation ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 TMG Health, ... to the Medicare Advantage, Medicare Part D and Managed ... Continuity and Resilience Team category at the BCI North ... Institute to recognize the outstanding contribution of business continuity ... North America Region, including the USA and Canada. The ...
Breaking Medicine News(10 mins):Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... , OMAHA, Neb. and PHOENIX, Ariz., June 30 ... Joseph,s Hospital and Medical Center in Phoenix today announced an ... school presence in Phoenix. , , The Phoenix ... School of Medicine at St. Joseph,s Hospital and Medical Center, ...
... infection to treat and requires six months of multiple ... pandemic, a shorter and simpler drug treatment would be ... settings with poor public health infrastructures. ... which TB patients could benefit from shorter treatment, researchers ...
... Community Improvement , , MINNEAPOLIS, June 30 ... and a leader in financial clearing services for health ... the Ernst & Young Entrepreneur Of The Year(R) 2009 ... region. According to Ernst & Young LLP, the award ...
... Partnership to Fight Chronic Disease (PFCD), a coalition committed to ... comprehensive health reform, hosted a breakfast meeting today where partner ... and care. , , America spends more ... percent - or $1.7 trillion - of that spending is ...
... Ultrasound in Medicine (AIUM) has reached a management ... (ISTU) effective July 1, 2009. The AIUM will ... functions in an effort to maximize the ISTU,s ... "The AIUM recognizes therapeutic ultrasound as a ...
... 30 /PRNewswire/ - Winnipeg-based medical device company Intelligent ... Century Achievement Award during the Computerworld Honors Program ... D.C. IH Systems received the award in recognition ... world,s first solution combining software, robotics and engineering ...
Cached Medicine News:Health News:Creighton University, St. Joseph's Hospital and Medical Center Announce New School of Medicine Campus in Phoenix 2Health News:Measurements fail to identify TB patients who could benefit from shorter treatment course 2Health News:SearchAmerica(R) President, Daniel Johnson, Named Ernst & Young Entrepreneur Of The Year(R) 2Health News:SearchAmerica(R) President, Daniel Johnson, Named Ernst & Young Entrepreneur Of The Year(R) 3Health News:Delaware's Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spending and Improved Patient Health 2Health News:Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society 2
... matrix constructed of cross-linked collagen fibers ... through a proprietary 360 accretion process. ... aspirate, Healos provides an excellent environment ... differentiation. The hydroxyapatite-coated collagen microfibers in ...
Sharp Weitlaner Retractor....
Weitlaner retractor, blunt....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
Medicine Products: